The current price of DFTX is $30.36 — it has decreased by 7.16% since the previous close. Data as of Nov 5, 2026.
DFTX is down 18.47% over the past week, down 16.20% over the past month and up 163.31% over the past year. The price is above its 200-day moving average of $14.26.
Analysts' average 12-month price target for DFTX is $67.45, which implies 122.17% upside from the current price. Individual estimates range from $52.00 to $79.00.
Of the 19 analysts covering Mind Medicine (MindMed) Inc., 5 rate it a strong buy and 14 rate it a buy. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Mind Medicine (MindMed) Inc. has a market capitalization of $4.08B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
Companies most comparable to Mind Medicine (MindMed) Inc. include Praxis Precision Medicines, Inc., Axsome Therapeutics, Inc., GH Research PLC, LB Pharmaceuticals Inc Common Stock and Rapport Therapeutics, Inc. Common Stock.
In the latest trading session DFTX moved between $30.17 and $32.33, a range of 7.11% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Mind Medicine (MindMed) Inc. shows a strong sell rating today and a sell rating on the weekly timeframe. Technical ratings are indicators, not investment advice.
Over the past 52 weeks DFTX has traded between $10.46 and $49.70. The current price is 38.91% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.